Meloxicam Biogaran (Meloxicam)

Meloxicam is used to manage inflammatory and painful conditions within the musculoskeletal disease spectrum.

• Osteoarthritis: reduces joint pain and improves functional ability.
• Rheumatoid arthritis: alleviates inflammation and slows joint damage progression.
• Ankylosing spondylitis: decreases spinal stiffness and associated pain.
• Acute pain: provides short‑term relief of moderate to severe pain.

• Meloxicam selectively inhibits cyclooxygenase‑2 (COX‑2) enzymes, with lesser effect on COX‑1, thereby decreasing the conversion of arachidonic acid to prostaglandins. The reduced prostaglandin synthesis diminishes inflammatory mediators at sites of tissue injury, leading to lowered pain perception, swelling, and fever. By targeting COX‑2, meloxicam maintains a more favorable gastrointestinal safety profile compared with non‑selective NSAIDs, while still providing effective anti‑inflammatory and analgesic activity.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dyspepsia or stomach upset
• Headache or dizziness
• Peripheral edema
• Skin rash or pruritus
• Mild elevation of liver enzymes

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding
• Cardiovascular events such as myocardial infarction
• Severe liver injury or hepatitis
• Acute renal failure or worsening of chronic kidney disease
• Anaphylactic or severe hypersensitivity reactions
• Stevens‑Johnson syndrome or toxic epidermal necrolysis

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risk.

• Assess gastrointestinal risk: evaluate history of ulcers or bleeding.
• Monitor cardiovascular status: use the lowest effective dose in patients with heart disease.
• Evaluate renal and hepatic function: check baseline labs and adjust if impairment is present.
• Avoid concomitant use with other NSAIDs or anticoagulants: increased bleeding risk.
• Store at ambient temperature: keep in the original container, protect from moisture.

Meloxicam can interact with other medicines, requiring careful review before co‑administration.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): heightened risk of bleeding.
• Other NSAIDs: additive gastrointestinal toxicity.
• Lithium: increased lithium serum concentrations.

Moderate Interactions (Monitor Closely)

• Diuretics: possible reduction in renal function.
• Methotrexate: enhanced methotrexate toxicity.
• Selective serotonin reuptake inhibitors (SSRIs): increased bleeding tendency.